CA
BSX icon

Corrado Advisors’s Boston Scientific BSX Stock Holding History

Corrado Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-28,635
Closed -$936K – 102
2018
Q2 		$936K Sell
28,635
-1,006
-3% -$30.3K 0.57% 44
2018
Q1 		$810K Buy
+29,641
New +$806K 0.49% 46

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Corrado Advisors's BSX Position: Q3 2018 in Review

Corrado Advisors sold out of Boston Scientific (BSX) in Q3 2018, closing a stake of 28,635 shares — an estimated $936K sold.

Corrado Advisors first reported a position in BSX in Q1 2018 and held it in 2 quarters. The position peaked at $936K in Q2 2018. 698 funds tracked by Wall St. Rank hold BSX as of Q3 2018.

  • Corrado Advisors reported no remaining Boston Scientific position as of Q3 2018 after selling out during the quarter.
  • Corrado Advisors sold 28,635 Boston Scientific shares in Q3 2018, an estimated $936K.
  • Corrado Advisors first reported a position in Boston Scientific in Q1 2018 and held it in 2 quarters.
  • Corrado Advisors's Boston Scientific position peaked at $936K in Q2 2018.
  • 698 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2018.

Based on Corrado Advisors's 13F filing for Q3 2018, filed 11 Oct 2018.